Fungal purulent constrictive pericarditis in a heart transplant patient

Ann Thorac Surg. 1998 Jun;65(6):1792-4. doi: 10.1016/s0003-4975(98)00277-x.

Abstract

Purulent pericarditis caused by Candida species is rare and is associated with very high mortality. Immunosuppressed transplant patients are particularly susceptible to fungal infections. We report a case of Candida purulent constrictive pericarditis in an immunocompromised heart transplant patient who was treated successfully with antifungal agents, surgical drainage, and pericardiectomy.

Publication types

  • Case Reports

MeSH terms

  • Amphotericin B / therapeutic use
  • Anti-Infective Agents / therapeutic use
  • Antifungal Agents / therapeutic use
  • Candidiasis / diagnosis*
  • Candidiasis / drug therapy
  • Candidiasis / surgery
  • Ciprofloxacin / therapeutic use
  • Disease Susceptibility
  • Drainage
  • Heart Transplantation*
  • Humans
  • Immunocompromised Host
  • Immunosuppression Therapy
  • Male
  • Middle Aged
  • Opportunistic Infections / diagnosis*
  • Opportunistic Infections / drug therapy
  • Opportunistic Infections / surgery
  • Pericardiectomy
  • Pericarditis, Constrictive / drug therapy
  • Pericarditis, Constrictive / microbiology*
  • Pericarditis, Constrictive / surgery
  • Pleural Effusion / microbiology
  • Pseudomonas Infections / diagnosis
  • Pseudomonas Infections / drug therapy
  • Pseudomonas aeruginosa
  • Suppuration

Substances

  • Anti-Infective Agents
  • Antifungal Agents
  • Ciprofloxacin
  • Amphotericin B